Immune Impact Induced by PROSTVAC (PSA-TRICOM), a Therapeutic Vaccine for Prostate Cancer

PSA-TRICOM (PROSTVAC) is a novel vector-based vaccine designed to generate a robust immune response against prostate-specific antigen (PSA)–expressing tumor cells. The purpose of this report is to present an overview of both published studies and new data in the evaluation of immune responses to the...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Gulley, James L., Madan, Ravi A., Tsang, Kwong Y., Jochems, Caroline, Marté, Jennifer L., Farsaci, Benedetto, Tucker, Jo A., Hodge, James W., Liewehr, David J., Steinberg, Seth M., Heery, Christopher R., Schlom, Jeffrey
Format: Artigo
Jezik:Inglês
Izdano: 2013
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4004961/
https://ncbi.nlm.nih.gov/pubmed/24778277
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2326-6066.CIR-13-0108
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items